{"id":8940,"date":"2020-05-07T15:57:52","date_gmt":"2020-05-07T13:57:52","guid":{"rendered":"https:\/\/www.resist-cluster.de\/?page_id=8940"},"modified":"2022-02-02T13:28:15","modified_gmt":"2022-02-02T12:28:15","slug":"pd-dr-susanne-eschenburg","status":"publish","type":"page","link":"https:\/\/www.resist-cluster.de\/en\/about-us\/research-team-2\/pd-dr-susanne-eschenburg\/","title":{"rendered":"PD Dr. Susanne Eschenburg"},"content":{"rendered":"

<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/a><\/span><\/div>

PD Dr. Susanne Eschenburg participates in RESIST research project B4.<\/p>\n<\/div>

<\/div><\/div><\/div>

\n\n\n
<\/i><\/td>\nMy Research Interest in RESIST<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/h1><\/div>

We work on the elucidation of the molecular mechanism of innate immune receptors of the NLRP family. These immune receptors constitute a first line of defense against invading pathogens. We combine a wide range of structural and cell biological methods to understand, how NLRPs function and how their function can be modulated.<\/p>\n

In particular we will analyse the interactions of pathogen- derived proteins with NLRPs and of small-molecule compounds that are known to inhibit selected NLRPs. Among our long-term goals is the structure-based development of lead compounds for the therapeutic modulation of the function of selected NLRPs.\u00a0<\/span><\/p>\n<\/div>

<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>

PD Dr. Eschenburg in the laboratory<\/h1><\/div>
<\/span><\/div>
<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>

PD Dr. Susanne Eschenburg – Curriculum Vitae<\/h1><\/div>
<\/div><\/div><\/div>

Current Position<\/h3><\/div>